GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Total Long-Term Assets

BITGF (Biotage AB) Total Long-Term Assets : $345.8 Mil (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Biotage AB's Total Long-Term Assets for the quarter that ended in Mar. 2025 was $345.8 Mil.


Biotage AB Total Long-Term Assets Historical Data

The historical data trend for Biotage AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Total Long-Term Assets Chart

Biotage AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.55 134.00 126.04 339.65 341.01

Biotage AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 351.25 347.29 354.58 341.01 345.81

Biotage AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


Biotage AB Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Biotage AB's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines

From GuruFocus

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021

Q3 2023 Biotage AB Earnings Call Transcript

By GuruFocus Research 03-03-2024

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021

Q1 2025 Biotage AB Earnings Call Transcript

By GuruFocus News 04-24-2025

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021

Q3 2024 Biotage AB Earnings Call Transcript

By GuruFocus News 10-24-2024

KKR Offers to Acquire Biotage AB for $1.2 Billion

By GuruFocus News 04-22-2025

Biotage AB (publ) Year-end report January - December 2021

By PRNewswire PRNewswire 02-11-2022